Pharmacological properties
Liasten belongs to immunomodulators of natural origin with a broad spectrum of activity. it represents fragments of a cell wall of lactobacilli. liasten stimulates function of macrophages and normalizes quantity of T lymphocytes; activates cells of a monocytic and macrophagic row, phagocytosis, increases activity of lizosomalny enzymes, products of active forms of oxygen, enhances cytotoxic effect of macrophages in relation to tumor cells. medicine strengthens synthesis of pro-inflammatory cytokines, in particular interleukin-1; increases cytotoxic activity of natural cages killers. the immunomodulatory activity of a liasten is shown also that medicine keeps endocrine function of a thymus gland, promotes reduction of the circulating cell-bound immune complexes. liasten promotes stimulation of a leukopoiesis, possesses weak anti-metastatic and antineoplastic action, reduces severity of side effects khimio- and radiation therapy. medicine has no embriotoksichesky, mutagen and teratogenic action.
Indication
byLiasten is appointed as immunomodulator at various diseases which are followed by secondary immunodeficience, a leukopenia, in particular at khimio- and radiation therapy of patients of an oncological profile and patients with a leukosis for the purpose of decrease in toxic action of tsitostatik; at intense and chronic radiation injuries; at surgical treatment of oncological diseases and patients of other categories. liasten it is shown at sharp and persistent bacterial and viral infections, for treatment of patients with a leukopenia of various origin.
Use Liasten in tablets is intended toby
for slow resorption in an oral cavity. it is desirable to rassasyvat slowly a tablet under language. usually appoint on 1 tablet 2 times a day. the course of treatment medicine usually makes 10–20 days if necessary it is possible to carry out repeated courses of treatment liasteny in 3–6 and 12 months
Contraindication
Hypersensitivity to medicine components.
Side effectsDrug is usually well transferred by
. sometimes perhaps short-term slight increase of body temperature which does not demand medicament withdrawal and holding special medical events. Special instructions
appointWith care by
to patients with allergic and autoimmune diseases. there is no experience of use of medicine during pregnancy and feeding by a breast. the ingestion of a tablet by the child or adult safely also does not demand additional medical actions. Storage conditions
At a temperature up to 25 °C.
Characteristics | |
Active ingredients | Glyukozaminilmuramildipeptid |
Amount of active ingredient | 2 mg |
Applicant | Enzyme |
Code of automatic telephone exchange | L03AX Other immunostimulators |
Interaction with food | It doesn't matter |
Light sensitivity | Not sensitive |
Origin | Biological |
Prescription status | According to the prescription |
Primary packing | blister |
Producer | DP ENZYME |
Quantity in packing | 20 tablets (2 blisters on 10 pieces) |
Release form | tablets for internal use |
Route of administration | Oral |
Sign | Domestic |
Storage temperature | from 5 °C to 25 °C |
Trade name | Liasten |
Liasten of the tab. of 2 mg No. 20
- Product Code: 176167
- In Stock
- Ready to ship
-
$89.88